Roivant Sciences Ltd. — Director's Dealing 2025

Nov 22, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Roivant Sciences Ltd. (ROIV)
CIK: 0001635088
Period of Report: 2025-11-19

Reporting Person: MANCHESTER KEITH S (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-11-19	Common Shares	S	850000	$20.25	Disposed	18497727	Indirect
2025-11-19	Common Shares	S	150000	$20.20	Disposed	18347727	Indirect
2025-11-19	Common Shares	S	125000	$20.16	Disposed	18222727	Indirect
2025-11-19	Common Shares	S	175000	$20.24	Disposed	18047727	Indirect

Footnotes

F1: The reporting person is a shareholder of QVT Financial Investment Cayman Ltd. ("QVT FIC") but does not have any voting or investment control over QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose.